National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

dexrazoxane hydrochloride (DEKS-ruh-ZOK-sane HY-droh-KLOR-ide)

 A drug used to treat severe side effects caused by certain anticancer drugs. It is used under the brand name Totect to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. It is also used under the brand name Zinecard to reduce heart damage in women given doxorubicin for breast cancer that has spread. Dexrazoxane hydrochloride is also being studied in the treatment of cancer. It is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.



Previous Definitions:DEXA, DEXA scan, dexamethasone, dexmethylphenidate, dexrazoxane
Next Definitions:dextroamphetamine-amphetamine, dextromethorphan acetic acid, DFMO, DHA-paclitaxel, DHEA

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov